NewsRx

Search our medical news database

Patents

Patent and Trademark Office Issues Notice of Allowance on Barr's Reissue Application for SEASONALE '032 Patent

Published in FDA Law Weekly, April 26th, 2007

Barr Pharmaceuticals, Inc. (NYSE: BRL) today announced that the U.S. Patent and Trademark Office (PTO) has issued a Notice of Allowance for the reissuance of U.S. Patent 5,895,032 ('032), relating to Barr's SEASONALE(R) extended-cycle oral contraceptive. The issuance of the Notice of Allowance confirms that Barr's reissue patent application has satisfied statutory requirements of patentability and indicates that the PTO will issue the reissue patent in the future.

"The PTO Notice of Allowance is the first step in a two step process. The next step will be formal reissuance of the SEASONALE patent which we can then list in the U.S. Food and Drug Administration's (FDA)...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of FDA Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook